Next Article in Journal
Maximum Tolerated Dose and Anti-Tumor Activity of Intraperitoneal Cantrixil (TRX-E-002-1) in Patients with Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer: Phase I Study Results
Next Article in Special Issue
Clinically Advanced Pheochromocytomas and Paragangliomas: A Comprehensive Genomic Profiling Study
Previous Article in Journal
Smart Biosensors for Cancer Diagnosis Based on Graphene Quantum Dots
Previous Article in Special Issue
Tracking the Antibody Immunome in Sporadic Colorectal Cancer by Using Antigen Self-Assembled Protein Arrays
 
 
Article

Article Versions Notes

Cancers 2021, 13(13), 3195; https://doi.org/10.3390/cancers13133195
Action Date Notes Link
article xml file uploaded 26 June 2021 12:06 CEST Original file -
article xml uploaded. 26 June 2021 12:06 CEST Update -
article pdf uploaded. 26 June 2021 12:06 CEST Version of Record https://www.mdpi.com/2072-6694/13/13/3195/pdf-vor
article supplementary file uploaded. 26 June 2021 12:06 CEST - https://www.mdpi.com/2072-6694/13/13/3195#supplementary
article html file updated 26 June 2021 12:07 CEST Original file -
article xml file uploaded 8 July 2021 04:02 CEST Update -
article xml uploaded. 8 July 2021 04:02 CEST Update https://www.mdpi.com/2072-6694/13/13/3195/xml
article pdf uploaded. 8 July 2021 04:02 CEST Updated version of record https://www.mdpi.com/2072-6694/13/13/3195/pdf
article html file updated 8 July 2021 04:03 CEST Update -
article html file updated 27 July 2022 02:07 CEST Update https://www.mdpi.com/2072-6694/13/13/3195/html
Back to TopTop